Event

Pneumonias are a leading cause of morbidity in all populations, but exact an extreme toll on patients with immunocompromising conditions. Advances in science and medicine have extended the spectrum of patients identified to be at high risk of pneumonia, both through an expanding array of immunosuppressive agents and regimens and through an increased ability to identify immune dysfunction in patients with chronic medical conditions not previously thought to impair host responses. This session will provide state of the art updates on diagnosis and management of immunocompromised host pneumonia with emphasis on novel mechanisms underlying immune dysfunction.